Clinical study for the treatment of children atopic dermatitis based on the theory of imbalance of dryness and dampness

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017916

Enrollment

Unknown

Registered

2018-08-21

Start date

2018-09-01

Completion date

Unknown

Last updated

2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group:Oral test drug

The control group:Oral test drug at 10% dose

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Chinese and western medicine for atopic dermatitis; 2. The syndrome was selected with reference to the diagnostic criteria of sicuryway in the TCM disease diagnosis and therapeutic effect standard; 3. Children with mild or moderate scores; 4. Children aged 6-12; 5. The guardian signs the informed consent with good compliance.

Exclusion criteria

Exclusion criteria: 1. Oral antihistamines within one week; 2. External use of glucocorticoid or calcineurin inhibitor; 3. Patients with liver and kidney dysfunction or severe systematic diseases, congenital diseases and immune diseases; 4. Other skin diseases, fungal (bacterial) infection, etc.; Combined with gastrointestinal diseases (e.g., enteritis, dysentery, etc.); 5. Allergic to medication; 6. Children participating in other clinical trials at the same time.

Design outcomes

Primary

Measure	Time frame
Scorad scores;	—

Secondary

Measure	Time frame
CDLQI;	—

Countries

China

Contacts

Public ContactNa Lang

Xiyuan Hospital CACMS

543550832@qq.com+86 13661140663

Outcome results